NO20050436L - Beta-layer-breaking peptides - Google Patents
Beta-layer-breaking peptidesInfo
- Publication number
- NO20050436L NO20050436L NO20050436A NO20050436A NO20050436L NO 20050436 L NO20050436 L NO 20050436L NO 20050436 A NO20050436 A NO 20050436A NO 20050436 A NO20050436 A NO 20050436A NO 20050436 L NO20050436 L NO 20050436L
- Authority
- NO
- Norway
- Prior art keywords
- layer
- beta
- peptides
- breaking
- breaking peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Det er tilveiebrakt peptider som har lagnedbrytende evne, som er nyttige til behandling og forhindring av sykdommer så som Alzheimers sykdom. Dementia pugilistica (inkludert hodetraume), arvelig cerebral blødning med amyloidose av den hollandske typen (HeHWA-D) og vaskulær demens med amyloid angiopati.There are peptides that have layer-breaking ability, which are useful for treating and preventing diseases such as Alzheimer's disease. Dementia pugilistica (including head trauma), hereditary cerebral haemorrhage with amyloidosis of the Dutch type (HeHWA-D) and vascular dementia with amyloid angiopathy.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02100787 | 2002-07-08 | ||
EP02102834 | 2002-12-19 | ||
PCT/EP2003/050287 WO2004005336A2 (en) | 2002-07-08 | 2003-07-07 | β-SHEET BREAKING PEPTIDES |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20050436D0 NO20050436D0 (en) | 2005-01-26 |
NO20050436L true NO20050436L (en) | 2005-01-26 |
Family
ID=30116915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20050436A NO20050436L (en) | 2002-07-08 | 2005-01-26 | Beta-layer-breaking peptides |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1532170A2 (en) |
JP (1) | JP2006508904A (en) |
AU (1) | AU2003271745A1 (en) |
CA (1) | CA2489754A1 (en) |
IL (1) | IL166102A0 (en) |
NO (1) | NO20050436L (en) |
WO (1) | WO2004005336A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130065042A1 (en) | 2011-03-11 | 2013-03-14 | The Board Of Trustees Of The University Of Illinois | Micro-Vascular Materials And Composites For Forming The Materials |
SG187271A1 (en) * | 2011-07-07 | 2013-02-28 | Agency Science Tech & Res | Anti-amyloidogenic, alpha-helix breaking ultra-small peptide therapeutic |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9917724D0 (en) * | 1999-07-28 | 1999-09-29 | Medical Res Council | Peptides |
WO2001034631A2 (en) * | 1999-11-05 | 2001-05-17 | Axonyx, Inc. | PEPTIDE ANALOGS AND MIMETICS SUITABLE FOR IN VIVO USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH ABNORMAL PROTEIN FOLDING INTO AMYLOID, AMYLOID-LIKE DEPOSITS OR β-SHEET RICH PATHOLOGICAL PRECURSOR THEREOF |
-
2003
- 2003-07-07 CA CA002489754A patent/CA2489754A1/en not_active Abandoned
- 2003-07-07 JP JP2004518784A patent/JP2006508904A/en active Pending
- 2003-07-07 WO PCT/EP2003/050287 patent/WO2004005336A2/en active Application Filing
- 2003-07-07 AU AU2003271745A patent/AU2003271745A1/en not_active Abandoned
- 2003-07-07 EP EP03753576A patent/EP1532170A2/en not_active Withdrawn
-
2005
- 2005-01-03 IL IL16610205A patent/IL166102A0/en unknown
- 2005-01-26 NO NO20050436A patent/NO20050436L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2006508904A (en) | 2006-03-16 |
CA2489754A1 (en) | 2004-01-15 |
EP1532170A2 (en) | 2005-05-25 |
NO20050436D0 (en) | 2005-01-26 |
WO2004005336A2 (en) | 2004-01-15 |
WO2004005336A3 (en) | 2004-02-26 |
AU2003271745A1 (en) | 2004-01-23 |
IL166102A0 (en) | 2006-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20052223L (en) | Thiazole compounds for the treatment of neurodegenerative disorders | |
DK2527315T3 (en) | Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease | |
NO961326D0 (en) | Inhibitors of | |
NO992463L (en) | N- (aryl / heteroarylacetyl) amino acid esters, pharmaceutical compositions including the same, and methods for inhibiting <beta> -amyloid peptide release and / or its synthesis using such compounds | |
NO20064726L (en) | Imidazole compounds for the treatment of neurodegenerative disorders | |
NO20053855L (en) | 1-Phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases. | |
NO20060768L (en) | 1- (2-Amino-benzene) -piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses | |
DE60219917D1 (en) | NAPHTOQUINONE DERIVATIVES AS INHIBITORS OF TAU AGGREGATION FOR THE TREATMENT OF ALZHEIMER'S AND ASSOCIATED NEURODEEGENERATIVE DISEASES | |
DK1567488T3 (en) | Hydroxyethylamine derivatives for the treatment of Alzheimer's disease | |
NO20060541L (en) | Pinerazine with OR-substituted phenyl grounds and their use as GlyT1 inhibitors | |
WO2004080376A3 (en) | Hydroxyethylamine compounds having asp2 inhibitory activity for the treatment of alzheimer’s disease | |
WO2007021886A3 (en) | Truncated memapsin 2 for use for treating alzheimer's disease | |
NO20064989L (en) | Sulfonamide compounds for the treatment of neurodegenerative disorders | |
DK2172208T3 (en) | Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders | |
ATE357438T1 (en) | 1,2,4-TRIAMINOBENZENE DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES | |
NO20055309D0 (en) | Slurp-1 coagulation schemes and methods for using them | |
NO20053237L (en) | Azapeptide. | |
NO20053341D0 (en) | Prevention and treatment of Alzheimer's disease. | |
NO20055668L (en) | Beta-amyloid inhibitors and their use | |
NO20070665L (en) | Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases | |
NO20050436L (en) | Beta-layer-breaking peptides | |
WO2004066940A3 (en) | Compositions and methods containing substituted quinolines and substituted diphenylsulfones | |
NO20065196L (en) | Therapeutic combination for the treatment of Alzheimer's disease | |
NO20074562L (en) | Procedures for the treatment of Parkinson's disease | |
DK0707477T3 (en) | Use of Efaxoran and its derivatives in the manufacture of drugs intended to treat neurodegenerative diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CREP | Change of representative |
Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS |
|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |